Unraveling the interplay between vital organelle stress and oxidative stress in idiopathic pulmonary fibrosis
- PMID: 38242330
- DOI: 10.1016/j.bbamcr.2024.119676
Unraveling the interplay between vital organelle stress and oxidative stress in idiopathic pulmonary fibrosis
Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disease characterized by excessive accumulation of extracellular matrix, leading to irreversible fibrosis. Emerging evidence suggests that endoplasmic reticulum (ER) stress, mitochondrial stress, and oxidative stress pathways play crucial roles in the pathogenesis of IPF. ER stress occurs when the protein folding capacity of the ER is overwhelmed, triggering the unfolded protein response (UPR) and contributing to protein misfolding and cellular stress in IPF. Concurrently, mitochondrial dysfunction involving dysregulation of key regulators, including PTEN-induced putative kinase 1 (PINK1), Parkin, peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), and sirtuin 3 (SIRT3), disrupts mitochondrial homeostasis and impairs cellular energy metabolism. This leads to increased reactive oxygen species (ROS) production, release of pro-fibrotic mediators, and activation of fibrotic pathways, exacerbating IPF progression. The UPR-induced ER stress further disrupts mitochondrial metabolism, resulting in altered mitochondrial mechanisms that increase the generation of ROS, resulting in further ER stress, creating a feedback loop that contributes to the progression of IPF. Oxidative stress also plays a pivotal role in IPF, as ROS-mediated activation of TGF-β, NF-κB, and MAPK pathways promotes inflammation and fibrotic responses. This review mainly focuses on the links between ER stress, mitochondrial dysfunctions, and oxidative stress with different signaling pathways involved in IPF. Understanding these mechanisms and targeting key molecules within these pathways may offer promising avenues for intervention.
Keywords: Endoplasmic reticulum stress; Idiopathic pulmonary fibrosis; Mitochondrial dysfunction; Oxidative stress; Signaling pathways; Unfolded protein response.
Copyright © 2024. Published by Elsevier B.V.
Conflict of interest statement
Declaration of competing interest The authors declare no conflict of interests.
Similar articles
-
Idiopathic pulmonary fibrosis (IPF): disease pathophysiology, targets, and potential therapeutic interventions.Mol Cell Biochem. 2024 Sep;479(9):2181-2194. doi: 10.1007/s11010-023-04845-6. Epub 2023 Sep 14. Mol Cell Biochem. 2024. PMID: 37707699 Review.
-
PGC-1α regulates endoplasmic reticulum stress in IPF-derived fibroblasts.Int Immunopharmacol. 2024 Sep 10;138:112514. doi: 10.1016/j.intimp.2024.112514. Epub 2024 Jun 28. Int Immunopharmacol. 2024. PMID: 38943974
-
Inflammation-Induced Protein Unfolding in Airway Smooth Muscle Triggers a Homeostatic Response in Mitochondria.Int J Mol Sci. 2020 Dec 31;22(1):363. doi: 10.3390/ijms22010363. Int J Mol Sci. 2020. PMID: 33396378 Free PMC article. Review.
-
Mitochondrial Quality Control in Age-Related Pulmonary Fibrosis.Int J Mol Sci. 2020 Jan 18;21(2):643. doi: 10.3390/ijms21020643. Int J Mol Sci. 2020. PMID: 31963720 Free PMC article. Review.
-
Amifostine ameliorates bleomycin-induced murine pulmonary fibrosis via NAD+/SIRT1/AMPK pathway-mediated effects on mitochondrial function and cellular metabolism.Eur J Med Res. 2024 Jan 20;29(1):68. doi: 10.1186/s40001-023-01623-4. Eur J Med Res. 2024. PMID: 38245795 Free PMC article.
Cited by
-
Gingival proteomics reveals the role of TGF beta and YAP/TAZ signaling in Raine syndrome fibrosis.Sci Rep. 2024 Apr 25;14(1):9497. doi: 10.1038/s41598-024-59713-0. Sci Rep. 2024. PMID: 38664418 Free PMC article.
-
Role of mitochondria in inflammatory lung diseases.Front Pharmacol. 2024 Aug 20;15:1433961. doi: 10.3389/fphar.2024.1433961. eCollection 2024. Front Pharmacol. 2024. PMID: 39228517 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials